November 5th, 2012
AHA 2012 Headquarters
CardioExchange Editors, Staff
CardioExchange is dedicated to bringing you the latest from AHA 2012. Check here often for coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting.
Previews:
News:
- Ultrafiltration Fails to Show Benefit in Acute Heart Failure
- RELAX-AHF Stirs Interest in Novel Drug for Acute Heart Failure
- Early Look: New Methods to Enhance Cholesterol Efflux
- Dalcetrapib: Another HDL-Raising CETP Inhibitor Bites the Dust
- FREEDOM Lends Strong Support to CABG for Diabetics with Multivessel Disease
- NIH Trial Gives Surprising Boost to Chelation Therapy
- ARCTIC Blows a Cold Wind on Platelet Function Tests
- ASPIRE: Aspirin an Attractive Alternative After First VTE
The Expert Is In:
- A New Era in ICD Therapy – Get with the Programming!
- Platelet-Function Testing in Coronary Stenting: Frozen in Its Tracks
Follow the Fellows:
- Closing Remarks from AHA
- Science, with a Little Bit of Flash
- Risk Prediction and Translation to Clinical Practice
- Poster Sessions: Better to Present or Observe?
- AHA — There’s an App for That!
- Breadth versus Depth at AHA
- What Tack to Take in Thinking about TACT?
- Using the Internet to Learn from Leaders in Cardiology
- Acknowledging our Mentors, Both Faculty and Peers
- Cardiology Circles and the AHA
- Late Breaking Trials vs. Abstract Oral Sessions
- What’s the Value of the Expo?
- Reclassifying AHA on the West Coast
- AHA with Some Perspective
- Management of Aortic Stenosis: Up Close and in Person
- The Benefits of Technology